According to data from MarketBeat, Horizon Therapeutics Public has a consensus rating of “Hold” and an average price target of $110.

Source: https://www.etfdailynews.com/2023/10/18/horizon-therapeutics-public-limited-nasdaqhznp-position-boosted-by-polaris-capital-management-llc/

According to data from MarketBeat, Kymera Therapeutics currently has an average rating of Moderate Buy and a consensus price target of $48.

Source: https://www.etfdailynews.com/2023/10/20/kymera-therapeutics-nasdaqkymr-given-market-perform-rating-at-leerink-partnrs/

Achilles Therapeutics has a consensus target price of $9.50, indicating a potential upside of 944.07%.

Source: https://www.etfdailynews.com/2023/10/01/financial-analysis-turnstone-biologics-nasdaqtsbx-vs-achilles-therapeutics-nasdaqachl/

Aclaris Therapeutics () last issued its quarterly earnings results on Tuesday, November 8th.

Source: https://www.etfdailynews.com/2023/02/11/fy2025-eps-estimates-for-aclaris-therapeutics-inc-nasdaqacrs-increased-by-analyst/

Acrivon Therapeutics has a 12 month low of $8.06 and a 12 month high of $25.47.

Source: https://www.americanbankingnews.com/2023/08/10/acrivon-therapeutics-inc-nasdaqacrv-receives-average-recommendation-of-buy-from-analysts.html

Adaptimmune Therapeutics () last released its quarterly earnings results on Tuesday, November 8th.

Source: https://www.etfdailynews.com/2023/02/02/cintia-piccina-sells-11890-shares-of-adaptimmune-therapeutics-plc-nasdaqadap-stock/

Aer Therapeutics, an Irish-founded biopharmaceutical spin-out company developing treatments for lung disease, has announced the close of a $36m Series A funding round today (14 April).

Source: https://biztoc.com/x/3959a35649fc91d3?ref=ff

A few examples include layoffs from ) stock news and why NeuBase Therapeutics) stock is on the move today.

Source: https://investorplace.com/2023/09/why-is-dutch-bros-bros-stock-down-8-today/

Akebia Therapeutics Enters into License Agreement with Medice Arzneimittel Pütter GmbH&.

Source: https://www.marketscreener.com/quote/stock/AKEBIA-THERAPEUTICS-INC-16068902/news/FDA-Provides-Akebia-Therapeutics-a-Path-Forward-for-Vadadustat-43988425/?utm_medium=RSS&utm_content=20230530

Akebia Therapeutics, Inc. has a 12 month low of $0.24 and a 12 month high of $1.84.

Source: https://www.etfdailynews.com/2023/09/03/140604-shares-in-akebia-therapeutics-inc-nasdaqakba-acquired-by-mirabella-financial-services-llp/

Allogene Therapeutics () last announced its quarterly earnings results on Wednesday, August 2nd.

Source: https://www.dailypolitical.com/2023/08/31/allogene-therapeutics-inc-nasdaqallo-short-interest-down-13-6-in-august.html

Also, General Counsel Paul T. Quinlan sold 5,000 shares of CymaBay Therapeutics stock in a transaction that occurred on Monday, October 16th.

Source: https://www.etfdailynews.com/2023/11/30/17700-shares-in-cymabay-therapeutics-inc-nasdaqcbay-acquired-by-boulder-hill-capital-management-lp/

Also, insider Eric Warren sold 5,090 shares of Esperion Therapeutics stock in a transaction that occurred on Tuesday, March 7th.

Source: https://www.americanbankingnews.com/2023/05/08/13774-shares-in-esperion-therapeutics-inc-nasdaqespr-purchased-by-fox-run-management-l-l-c.html

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs.

Source: https://www.dailypolitical.com/2023/01/02/altamira-therapeutics-ltd-nasdaqcyto-sees-large-decline-in-short-interest.html

Amalgamated Bank lowered its holdings in shares of Horizon Therapeutics Public Limited () by 6.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).

Source: https://www.etfdailynews.com/2023/02/21/amalgamated-bank-sells-1626-shares-of-horizon-therapeutics-public-limited-nasdaqhznp/

American International Group Inc. boosted its position in shares of Travere Therapeutics, Inc. () by 18.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

Source: https://www.americanbankingnews.com/2023/11/18/american-international-group-inc-purchases-5365-shares-of-travere-therapeutics-inc-nasdaqtvtx.html

Ameritas Investment Partners Inc. grew its holdings in shares of PTC Therapeutics by 3.6% during the 1st quarter.

Source: https://www.etfdailynews.com/2023/05/20/citigroup-boosts-ptc-therapeutics-nasdaqptct-price-target-to-70-00/

Amit Munshi had to beg off when he was first introduced to the idea of running an MPM BioImpact stealth player named ReNAgade Therapeutics.

Source: https://biztoc.com/x/96d9943ab7d28d40?ref=ff

Among that is what has shares of Intelligent Bio Solutions Fresh Tracks Therapeutics ) stock moving today.

Source: https://investorplace.com/2023/03/why-is-occidental-petroleum-oxy-stock-up-today-march-8/

Analysts predict that Corcept Therapeutics will post 0.8 EPS for the current fiscal year.

Source: https://www.dailypolitical.com/2023/11/05/corcept-therapeutics-nasdaqcort-rating-increased-to-strong-buy-at-stocknews-com.html